Autism dietary supplement OSR#1 sales halted, FDA calls unapproved

Trine Tsouderos


Pharmacies are halting sales of OSR#1, a compound marketed as a dietary supplement to parents of children with autism, six weeks after the U.S. Food and Drug Administration called the product an unapproved new drug.

Several pharmacists told the Chicago Tribune they received an e-mail last week from Boyd Haley, president of the company that makes the product, informing them that OSR#1 would not be available after Thursday.

One online pharmacy, Forrest Health, posted this message: "CTI Science has voluntarily agreed to remove OSR#1® from the market effective Thursday, 29 July 2010."

The product, sold as a toxicity-free antioxidant supplement, was featured on autism Web sites such as Age of Autism, whose managing editor described sprinkling it in her children's juice and breakfast sandwiches.

The Tribune reported in January that the compound had been developed as an industrial chemical used to treat mining wastewater, an issue apparently first raised by blogger Kathleen Seidel of neurodiversity.com.

On June 17, the FDA sent Haley a warning letter calling the product an unapproved new drug with false or misleading labeling regarding side effects. Failing to correct such violations can result in fines, seizure of products and even criminal prosecution.

Haley did not respond to requests for an interview Monday. An FDA spokeswoman said the agency had not heard from Haley or CTI Science.

Ellen Silbergeld, an expert in environmental health who is studying mercury and autism at Johns Hopkins University's Bloomberg School of Public Health, urged the FDA to monitor the company to ensure it does not continue selling the product.

"It is welcome news, but in these conditions, without government action, the situation remains unsettled," Silbergeld said.

A number of pharmacies listed on the CTI Science Web site as sellers of the product reported they were no longer selling OSR#1.

"We sold out last week," said pharmacist Kurt Moyer of Dr. Aziz Pharmacy in Indianapolis, which last week posted a message on the company Facebook page: "OSR#1 will no longer be available after July 29, 2010 and there is no anticipated release date, so once we sell out we will not be able to order additional stock."

Full story from the LA Time here


Related Articles


Gentle horses help rein in childhood autism

Over the eight years that Mary Cusack has been raising her son, Nicky, she's become familiar with finger 'stim ..

read more

Senior portrait for high school grad leads to modeling gig

All Cole Emory wanted for his 18th birthday last August was a tuxedo he could wear in his senior portrait. An ..

read more

Voice analysis may help ID autism early

Analyzing a child's voice may someday be a way to screen children for autism, according to a new study. "Wh ..

read more

Our Support Community


Join our free support community and connect with thousands of other families and individuals touched by ASD. Find out what’s working for others, coping strategies, and life guides from others living what you’re going through now. Click here to join for free!

Resources in Your Area

Looking for autism resources nearby? Check our listings for professionals and services that might help.

Post your services | Help out in general

Events


31st Pacific Rim International Conference on Disability and Diversity
Honolulu, HI - United States
May-18-2015 - 12:00 am
You can’t miss the 31st Annual Pacific Rim Conference on Disability and Diversity, May 18 & 19, 2015 at the Hawaii Convention Center in Honolulu. The theme for our ..
Go to Event site

view all events